Safety and efficacy of recombinant activated factor VII in nonhemophilia children with severe or life-threatening bleeding
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Hematology,General Medicine
Reference26 articles.
1. Use of human factor VIIa in the treatment of two haemophilia A patients with high-titre inhibitors.;Hedner;J Clin Invest,1983
2. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.;Hedner;Lancet,1988
3. Recombinant activated factor VII use in critically ill infants with active hemorrhage.;Jen;J Pediatr Surg,2008
4. Tissue factor and factor VIIa as therapeutic targets in disorders of haemostasis.;Hedner;Annu Rev Med,2008
5. Treatment of traumatic bleeding with recombinant factor VIIa.;Kenet;Lancet,1999
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis;International Journal of Molecular Sciences;2021-01-14
2. Efficacy and Safety of Recombinant Activated Factor VII Off-label Use in a Pediatric Hematology/Oncology Cohort;Journal of Pediatric Hematology/Oncology;2019-03
3. Medications for Hemostasis;A Practice of Anesthesia for Infants and Children;2019
4. The current state of adverse event reporting in hemophilia;Expert Review of Hematology;2016-12-26
5. Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients;Korean Journal of Pediatrics;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3